Opinion|Videos|November 26, 2024

The Role of Testing for C Difficile in Clinical Practice

Key Takeaways

  • Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure.
  • Early testing facilitates prompt diagnosis and management, influencing treatment initiation timing.
SHOW MORE

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors such as recent antibiotic use, hospitalization, or older age, and how empiric treatment should be initiated while awaiting test results if there is high clinical suspension.

Video content above is prompted by the following:

  • In which patients do you test for C difficile before treating?
  • Does the timing of the testing influence when you start treatment?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo